Datti Fernanda, Datti Marcelo, Antunes Edson
Department of Pharmacology, Faculty of Medical Sciences, State University of Campinas, PO Box 6111, Campinas 13084-971, SP, Brazil.
Pulm Pharmacol Ther. 2008;21(2):349-55. doi: 10.1016/j.pupt.2007.09.001. Epub 2007 Sep 15.
A correlation between stressful events experienced by the mother during pregnancy and progression of respiratory disease in descendants has been reported. Prenatal exposure to lipopolyssacharide (LPS) reduces allergic airway inflammation in mice offspring. In this study we investigated whether reduction of airways inflammation by maternal LPS exposure involves activation of inducible nitric oxide synthase (iNOS) at prenatal life. Since LPS also induces the release of TNF-alpha, and that this cytokine has been implicated in pathogenesis of asthma, we also evaluated whether TNF-alpha plays a role in the allergic airways inflammation by maternal LPS exposure. Pregnant rats were pretreated with the iNOS inhibitor aminoguanidine (50mg/rat per day; given from day 13 of gestation up to delivery) before exposure to LPS (7mug/kg, given at day 17 of gestation). At adult ages, female and male offspring were sensitized with ovalbumin (OVA), and 14 days later they were challenged with this allergen. OVA challenge in sensitized offspring increased markedly the eosinophil number in bronchoalveolar lavage (BAL) fluid at 48h compared with the non-sensitized group. However, the eosinophil number was largely reduced in offspring from maternal LPS exposure, irrespective of offspring gender. Maternal pretreatment with aminoguanidine fully reversed the eosinophil suppression by LPS. The maternal LPS exposure also reduced the eosinophil number in bone marrow and peripheral blood of offspring, but this was not affected by aminoguanidine. No differences in TNF-alpha levels in BAL fluid were found. In conclusion, our study shows that maternal LPS exposure markedly reduces allergic airways eosinophil recruitment in adult offspring by mechanisms possibly involving iNOS activation.
据报道,母亲在孕期经历的应激事件与后代呼吸系统疾病的进展之间存在关联。产前暴露于脂多糖(LPS)可减轻小鼠后代的过敏性气道炎症。在本研究中,我们调查了母体LPS暴露减轻气道炎症是否涉及产前诱导型一氧化氮合酶(iNOS)的激活。由于LPS还可诱导肿瘤坏死因子-α(TNF-α)的释放,且该细胞因子与哮喘发病机制有关,我们还评估了TNF-α在母体LPS暴露所致过敏性气道炎症中是否起作用。妊娠大鼠在暴露于LPS(妊娠第17天给予7μg/kg)之前,先用iNOS抑制剂氨基胍(50mg/大鼠/天;从妊娠第13天至分娩给药)进行预处理。成年后,雌雄后代均用卵清蛋白(OVA)致敏,14天后用该变应原进行激发。与未致敏组相比,致敏后代接受OVA激发后48小时,支气管肺泡灌洗(BAL)液中的嗜酸性粒细胞数量显著增加。然而,无论后代性别如何,母体LPS暴露后代的嗜酸性粒细胞数量均大幅减少。母体用氨基胍预处理可完全逆转LPS对嗜酸性粒细胞的抑制作用。母体LPS暴露还可减少后代骨髓和外周血中的嗜酸性粒细胞数量,但不受氨基胍影响。BAL液中TNF-α水平未发现差异。总之,我们的研究表明,母体LPS暴露可通过可能涉及iNOS激活的机制,显著减少成年后代过敏性气道嗜酸性粒细胞的募集。